KOR ENG JPN
KOR ENG JPN

Evaluation Field

home

Evaluation Field

더보기

Clinical Trial

Safety Test

Clinical Trial Safety Test Efficacy Test for Cosmetics Efficacy Test for Cosmeceuticals In vitro assay Safety Test Efficacy Test

Safety Test

    • Safety-in-use test
    • The test can be determined the subjects'(nomal skin, children skin, sensitive skin, sensitive eyes, sensitive scalp) tolerance of the test material under the nomal use condition.

    • Test Period

      4 weeks

    • Subject

      More than 26 subjests

    • Claim

      Dermapro safety tested
      Safety test on human skin
      Non-irritation
      Safety-in-use tested
      DermatologIcally tested
      Ophthalmologically tested
      Pediatrically tested

    • Skin sensory irritation test
    • The test materials apply to the nasolabial fold of the sensitive skin(stinger selected by 5% lactic acid sting test)to campare and evaluate the sensory irritation.

    • Test Period

      2 weeks

    • Subject

      More than 10 subjests

    • Claim

      Dermapro safety tested
      Safety test on human skin
      DermatologIcally tested

    • Skin sensitivity test
    • The test can be evaluated the improvement of the skin sensitivity measured by CPT value, questionnaire, etc.

    • Test Period

      4 weeks

    • Subject

      More than 20 subjests

    • Claim

      Dermapro safety tested
      Safety test on human skin
      DermatologIcally tested

    • Photo-allergy patch test
    • After repeat exposure the test material and irradiation on the same site, apply the test material and irradiate UV to another site to determine whether it causes allergic reaction.

    • Test Period

      6 weeks

    • Subject

      More than 26 subjests

    • Claim

      Dermapro safety tested
      Safety test on human skin
      Dermatologically tested
      Non-photosensitization
      Hypo-photoallergenic

    • Repeated insult patch test
    • The test is used for predicting the dermal sensitization potency caused by an ingredient in the test material. After repeat exposure the test material on the same site, apply the test material to another site to determine whether it causes allergic reacti

    • Test Period

      6 weeks

    • Subject

      More than 50 subjests

    • Claim

      Dermapro safety tested
      Safety test on human skin
      DermatologIcally tested
      Hypo-allergenic
      Non-sensitization

    • Photo-irritaion patch test
    • Test material is applied in duplicate and one site is irradiated with UVR. Irradiated and non-irradiated sites are evaluated and compared for skin reaction.

    • Test Period

      1 week

    • Subject

      More than 12 subjects

    • Claim

      Dermapro safety tested
      Safety test on human skin
      DermatologIcally tested
      Photoirritation tested
      Non-photoirritation

    • Cumulative application patch test
    • The test is used for screening irritation from skin barrier disruption caused repetitive use of the finished products or its ingredients, especially cleanser, on human skin. The cumulative irritation is evaluated through repetitive application of the test

    • Test Period

      3 weeks

    • Subject

      More than 25 subjects

    • Claim

      Dermapro safety tested
      Safety test on human skin
      DermatologIcally tested
      non-cumulative irritation

    • Single application patch test
    • The test is used for screening irritation of the finished products or its ingredients on human skin. The test sites are evaluated for skin reaction 24 and 48 hours after patching the test materials.

    • Test Period

      1 week

    • Subject

      More than 30 subjects

    • Claim

      Dermapro safety tested
      Safety test on human skin
      DermatologIcally tested
      non-irritation